Effect of Cardiac Glycosides on Active Na-K-Transport

  • Hans J. Schatzmann

Abstract

In 1953 it became clear from work with human red cells that the K-loss from cells treated with cardiac glycosides (or their aglucones) is due to inhibition of active Na-K-transport [1]. The inhibition of the Na-pump was later demonstrated in most cells showing active Na-K-transport, ranging from the frog skin epithelium to the cells of the ciliary body of the human eye [2–14].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Schatzmann, H. J., 1953: Hely. Physiol. Acta 11, 346.Google Scholar
  2. [2]
    Glynn, I. M., 1957: J. Physiol. 136, 148.Google Scholar
  3. [3]
    Kahn, J. B., jr., 1961: Proc. 1st Intern. Pharmacol. Meeting, vol. III, p. 111.Google Scholar
  4. [4]
    Johnson, J. A., 1956: Amer. J. Physiol. 187, 328Google Scholar
  5. [5]
    Sehreiber, S., 1956: Amer. J. Physiol. 185, 337.Google Scholar
  6. [6]
    Koefoed-Johnson, J. V., 1957: Acta Physiol. Scand. 42, Suppl. 145.Google Scholar
  7. [7]
    Caldwell, P. C., and R. D. Keynes, 1959: J. Physiol. 148, 8 P.Google Scholar
  8. [8]
    Orloff, J., and M. Burg, 1960: Amer. J. Physiol. 199, 49.Google Scholar
  9. [9]
    Wilde, W. S., and P. J. Howard, 1960: J. Pharm. Exper. Ther. 130, 232.Google Scholar
  10. [10]
    Horowicz, P., and C. J. Gerber, 1965: J. Gen. Physiol, 48, 489.CrossRefGoogle Scholar
  11. [11]
    Kleinzeller, A., and A. Knotkova, 1964: J. Physiol. 175, 172.Google Scholar
  12. [12]
    Simon, K. A., and S. L. Bonting, 1962: A. M. A. Arch. Ophthalm. 68,22.Google Scholar
  13. [13]
    Daniel, E. E., and K. Rob-Robinson, 1966: J. Physiol. 154, 445.Google Scholar
  14. [14]
    Kao, C. Y., and D. Zakim, 1962: J. Gen. Physiol, 45, 606 A.Google Scholar
  15. [15]
    Whittam, R., 1958: J. Physiol. 140, 479.Google Scholar
  16. [16]
    Sen, A. K., and R. L. Post, 1964: J. Biol. Chem. 239, 345.Google Scholar
  17. [17]
    Skou, J. C., 1957: Biochim. Biophys. Acta 23, 394.CrossRefGoogle Scholar
  18. [18]
    Repke, K., 1964: Arzneimittelforsch. 14, 1073.Google Scholar
  19. [19]
    Dransfeld, H., and K. Greeff, 1964: Arch. Exper. Path. Pharm. 249, 425.Google Scholar
  20. [20]
    Kahn, J. B., jr., 1962: Proc. Soc. Exper. Biol. Med. 110, 412.CrossRefGoogle Scholar
  21. [21]
    Gallois, and Hardy, 1876: J. de Pharmacie et de Chimie 24, 25.Google Scholar
  22. [22]
    Harnack, E., and R. Zabrocki, 1882: Arch. Exper. Path. Pharm. 15, 403.CrossRefGoogle Scholar
  23. [23]
    Santi, R., 1939: Arch. Exper. Path. Pharm. 193, 152.CrossRefGoogle Scholar
  24. [24]
    Maling, H. M., and O. Krayer, 1946: J. Pharmacol, Exper. Ther. 86, 66.Google Scholar
  25. [25]
    Kroneberg, G., K. H. Meyer, E. Schraufstätter, S. Schütz, and K. Stoepel, 1964: Naturwissenschaften 51, 192.CrossRefGoogle Scholar
  26. [26]
    Kroneberg, G., and K. Stoepel, 1964: Arch. Exper, Path. Pharm. 249, 393.Google Scholar
  27. [27]
    Greeff, K., K. Meng, and D. Schwarzmann, 1964: Arch. Exper. Path. Pharm. 249, 416.Google Scholar
  28. [28]
    Glynn, I. M., 1962: J. Physiol. 160, 18 P.Google Scholar
  29. [29]
    Whittam, R., 1962: Biochem. J. 84, 110.Google Scholar
  30. [30]
    Whittam, R., M. Ager, 1962: Biochim. Biophys. Acta 65, 383.CrossRefGoogle Scholar
  31. [31]
    Post, R. L., C. R. Merritt, C. R. Kinsolving, and C. D. Albright, 1960: J. Biol. Chem. 235, 1796.Google Scholar
  32. [32]
    Dunham, E. T., and I. M. Glynn, 1961: J. Physiol. 156, 274.Google Scholar
  33. [33]
    Post, R. L., A. K. Sen, and A. S. Rosenthal, 1965: J. Biel. Chem. 240, 1437.Google Scholar
  34. [34]
    Hokin, M. R., and L. E. Hokin, 1961: Lab. Invest. 10, 1151.Google Scholar
  35. [35]
    Judah, J. D., and K. Ahmed, 1964: Biol. Rev. 39, 160.CrossRefGoogle Scholar
  36. [36]
    Whittam, R., and K. P. Wheeler, 1961: Biochim. Biophys. Acta 51, 622.CrossRefGoogle Scholar
  37. [37]
    Repke, K., and H. J. Portius, 1963: Experientia 19, 452.CrossRefGoogle Scholar
  38. [38]
    Schatzmann, H., 1965: Biochim. Biophys. Acta 94, 89.CrossRefGoogle Scholar
  39. [39]
    Schatzmann, H., 1964: Experientia 20, 551.CrossRefGoogle Scholar
  40. [40]
    Schatzmann, H., 1963: Hely.,Physiol. Acta 21, C 60.Google Scholar
  41. [41]
    Straub, F. B., 1954: Acta Physiol. Acad. Sci. Hung. 4, 235.Google Scholar
  42. [42]
    Schatzmann, H., and B. Raess, 1965: Hely. Physiol, Acta 22, C 47.Google Scholar

Copyright information

© Springer-Verlag Wien 1967

Authors and Affiliations

  • Hans J. Schatzmann
    • 1
  1. 1.Department of PharmacologyUniversity of BerneSwitzerland

Personalised recommendations